Abstract
Saitohin (STH) is an intronless gene nested within the human tau gene, which contains a single nucleotide polymorphism (A/G), suggested to be involved in the physiopathology and clinical course of several neurodegenerative and neuropsychiatric diseases. Recently, an association between this polymorphism and frontal hypoperfusion and clinical prognosis in frontotemporal dementia was reported. The present study sought to evaluate the possible role of the STH polymorphism as a concurring factor of cognitive decline in schizophrenia, a disease sharing both early psychotic manifestations, a core deficit of executive functions and hypofrontality with frontotemporal lobe dementia. 220 clinically stabilized patients with schizophrenia were assessed with the Wisconsin Card Sorting Test (WCST) for evaluation of executive functions and compared for STH allele frequency with 48 patients affected by frontotemporal dementia and 47 healthy subjects. There was no significant difference in allelic distribution between the healthy controls and all other groups, while we observed a significantly greater frequency of G allele among both patients with frontotemporal dementia (p = 0.037) and schizophrenia patients with poor performances of WCST (p = 0.044), compared to schizophrenia patients with best WCST performances. Among the patients with schizophrenia, stratified for age and gender, the STH polymorphism resulted in a significant predictor of WCST performance (p = 0.007). These results suggest a possible contribution of STH gene products on the heterogeneity of core frontal executive functions deterioration, probably through complex interactions with mechanism involved in neurodevelopment and neurodegeneration.
Similar content being viewed by others
References
Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J et al (2004) Molecular evolution and genetics of the saitohin gene and tau haplotype in Alzheimer’s disease and argyrophilic grain disease. J Neurochem 89:179–188
Verpillat P, Ricard S, Hannequin D, Dubois B, Bou J, Camuzat A et al (2002) Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol 52:829–832
Kwok JB, Teber ET, Loy C, Hallupp M, Nicholson G, Mellick GD et al (2004) Tau haplotypes regulate transcription and are associated with Parkinson’s disease. Ann Neurol 55:329–334
Gao L, Tse SW, Andreadis A, Conrad C (2005) Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6. J Biol Chem 280:39268–39272
de Silva R, Hope A, Pittman A, Weale ME, Morris HR, Wood NW et al (2003) Strong association of the saitohin gene Q7 variant with progressive supranuclear palsy. Neurology 61:407–409
Jankovic N, Kecmanovic M, Dimitrijevic R, Markovic M, Dobricic V, Keckarevic D et al (2008) HD phenocopies—possible role of saitohin gene. Int J Neurosci 118:391–397
Levecque C, Elbaz A, Clavel J, Vidal JS, Amouyel P, Alpérovitch A et al (2004) Association of polymorphisms in the tau and saitohin genes with Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:478–480
Conrad C, Vianna C, Freeman M, Davies P (2002) A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer’s disease. Proc Natl Acad Sci USA 99:7751–7756
Clark LN, Levy G, Tang MX, Santana H, Ciappa A, Tycko B et al (2003) The saitohin ‘Q7R’ polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson’s disease cohorts. Neurosci Lett 347:17–20
Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ et al (2002) No evidence for an association between saitohin Q7R polymorphism and Alzheimer’s disease. Ann Neurol 52:690–691
Streffer JR, Papassotiropoulos A, Kurosinski P, Signorelli A, Wollmer MA, Tsolaki M et al (2003) Saitohin gene is not associated with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 74:362–363
Lorenzi C, Marcone A, Pirovano A, Marino E, Cordici F, Cerami C, Delmonte D, Cappa SF, Bramanti P, Smeraldi E (2010) Serotonin transporter and saitohin genes in risk of Alzheimer’s disease and frontotemporal lobar dementia: preliminary findings. Neurol Sci 31:741–749
Borroni B, Paghera B, Agosti C, Anchisi D, Perani D, Archetti S et al (2008) Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders. Acta Neurol Scand 117:359–366
Borroni B, Grassi M, Agosti C, Alberici A, Premi E, Archetti S et al (2010) Establishing short-term prognosis in frontotemporal lobar degeneration spectrum: role of genetic background and clinical phenotype. Neurobiol Aging 31(2):270–279
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913–4917
Hong M, Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547–19553
Rapp MA, Schnaider-Beeri M, Purhoit DP, Reichenberg A, McGurk SR, Haroutunian V, Harvey PD (2010) Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients. Schizophr Res 116:90–96
Costa E, Chen Y, Davis J, Dong E, Noh JS, Tremolizzo L et al (2002) Reelin and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv 2:47–57
Guidotti A, Auta J, Davis M, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57:1061–1069
Bock HH, Herz J (2003) Reelin activates src family tyrosine kinases in neurons. Curr Biol 13:18–26
Rice DS, Curran T (1999) Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. Genes Dev 13:2758–2773
Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P et al (2001) Downregulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci USA 98:3477–3482
Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant-Maréchal L, Le Ber I, Campion D (2010) Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry 197:28–35
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276
Stratta P, Arduini L, Daneluzzo E, Rinaldi O, Di Genova A, Rossi A (2004) Relationship of good and poor Wisconsin Card Sorting Test performance to illness duration in schizophrenia: a cross-sectional analysis. Psychiatry Res 121:219–227
Cavallaro R, Cavedini P, Mistretta P, Bassi T, Angelone SM, Ubbiali A et al (2003) Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry 54:437–443
Ermoli E, Anselmetti S, Bechi M, Cocchi F, Smeraldi E, Cavallaro R (2005) Assessment of psychosis in schizophrenia: neuropsychological profile of chronic schizophrenia. Clin Neuropsychiatry 2:243–249
Johansson A, Zetterberg H, Håkansson A, Nissbrandt H, Blennow K (2005) TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer’s disease and are not associated with frontotemporal dementia or Parkinson’s disease. Neurodegener Dis 2:28–35
Karlsgodt KH, Sanz J, van Erp TG, Bearden CE, Nuechterlein KH, Cannon TD (2009) Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia. Schizophr Res 108:143–150
Brigman JL, Padukiewicz KE, Sutherland ML, Rothblat LA (2006) Executive functions in the heterozygous reeler mouse model of schizophrenia. Behav Neurosci 120:984–988
Gold J (1998) Schizophrenia and intellectual decline. Am J Psychiatry 155:1633–1634
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bosia, M., Buonocore, M., Guglielmino, C. et al. Saitohin polymorphism and executive dysfunction in schizophrenia. Neurol Sci 33, 1051–1056 (2012). https://doi.org/10.1007/s10072-011-0893-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-011-0893-9